Skip to content

Advertisement

Articles

Sort by
Page 1 of 7
  1. Content type: Research

    Peripheral arterial disease (PAD) has much impact on mortality in hemodialysis (HD) patients. Ankle-brachial index (ABI) and skin perfusion pressure (SPP) are useful tools to detect PAD in HD patients. However...

    Authors: Kunihiro Ishioka, Takayasu Ohtake, Hidekazu Moriya, Yasuhiro Mochida, Machiko Oka, Kyoko Maesato, Sumi Hidaka and Shuzo Kobayashi

    Citation: Renal Replacement Therapy 2018 4:27

    Published on:

  2. Content type: Research

    Pruritus in patients undergoing hemodialysis reduces quality of life via insomnia and depression, and negatively affects prognosis. For diagnosing pruritus, selecting therapeutic strategies, and determining th...

    Authors: Naoko Takahashi, Taku Yoshizawa, Aiko Okubo, Junko Kumagai, Hideki Kawanishi, Shinichiro Tsuchiya, Misaki Moriishi, Takao Masaki and Toshiya Ebata

    Citation: Renal Replacement Therapy 2018 4:26

    Published on:

  3. Content type: Case Report

    Tuberous sclerosis complex is an autosomal dominant genetic disorder that affects multiple organ systems and can result in tumors in the brain, skin, heart, and kidneys; it may also cause neurological symptoms...

    Authors: Akira Ashida, Hideki Matsumura, Yuko Fujii, Hyogo Nakakura, Akihiko Shirasu and Hiroshi Tamai

    Citation: Renal Replacement Therapy 2018 4:25

    Published on:

  4. Content type: Research

    Low tongue pressure contributes to oral frailty. It is a condition in which the pressure between the tongue, palate, and food decreases due to a decrease in tongue muscle function. Low tongue pressure interfer...

    Authors: Yuka Kamijo, Eiichiro Kanda, Keisuke Ono, Keizo Maeda, Akane Yanai, Kazuya Honda, Ryuji Tsujimoto, Mai Yanagi, Yoshitaka Ishibashi and Masayuki Yoshida

    Citation: Renal Replacement Therapy 2018 4:23

    Published on:

  5. Content type: Case Report

    Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited disease among primary diseases in dialysis patients. Tolvaptan is known to improve increases in total kidney volume (TKV) in pa...

    Authors: Shuma Hirashio, Shigehiro Doi and Takao Masaki

    Citation: Renal Replacement Therapy 2018 4:24

    Published on:

  6. Content type: Case Report

    Infection is the second leading cause of mortality in patients who undergo maintenance hemodialysis. In this population, impairment in both cellular and humoral immunity contributes to the increased incidence ...

    Authors: Shunsuke Yamada, Narihito Tatsumoto, Noriko Nakamura, Kosuke Masutani, Toshiro Maeda, Takanari Kitazono and Kazuhiko Tsuruya

    Citation: Renal Replacement Therapy 2018 4:22

    Published on:

  7. Content type: Research

    Chronic kidney disease (CKD) is one of the main public health issues. It increases the morbidity and mortality of patients. Treatment includes multiple aspects such as dialysis and lifestyle modifications. The...

    Authors: Ibrahim Mousa, Raed Ataba, Khaled Al-ali, Abdulsalam Alkaiyat and Sa’ed H. Zyoud

    Citation: Renal Replacement Therapy 2018 4:21

    Published on:

  8. Content type: Research

    Hemodialysis catheters are commonly used for vascular access in patients undergoing blood purification therapies. However, the sudden dysfunction of catheters represents a serious problem, and while we know th...

    Authors: Yoshimitsu Takahashi, Junichiro J. Kazama, Suguru Yamamoto, Takashi Oite and Ichiei Narita

    Citation: Renal Replacement Therapy 2018 4:20

    Published on:

  9. Content type: Case Report

    Patients with end-stage renal failure may exhibit sarcopenia and protein-energy wasting (PEW). We report a case of improvement in physical function, muscle mass, and muscle strength by management of rehabilita...

    Authors: Chiharu Uno, Hidetaka Wakabayashi, Keisuke Maeda and Shinta Nishioka

    Citation: Renal Replacement Therapy 2018 4:18

    Published on:

  10. Content type: Research

    Asymptomatic peripheral artery disease (PAD) increases the risk of mortality in non-hemodialysis patients. However, the association between asymptomatic PAD and mortality rate remains unclear in patients on he...

    Authors: Manae Harada, Ryota Matsuzawa, Naoyoshi Aoyama, Kaoru Uemura, Yoriko Horiguchi, Junko Yoneyama, Keika Hoshi, Kei Yoneki, Takaaki Watanabe, Takahiro Shimoda, Yasuo Takeuchi, Shokichi Naito, Atsushi Yoshida and Atsuhiko Matsunaga

    Citation: Renal Replacement Therapy 2018 4:17

    Published on:

  11. Content type: Research

    l-carnitine is essential for lipid metabolism, and lack of l-carnitine intake and loss by treatments lead to carnitine depletion causing muscle weakness, anemia, and immune dysfunction. Carnitine depletion occurs...

    Authors: Takehiko Oami, Taku Oshima, Noriyuki Hattori, Ayako Teratani, Saori Honda, Toshihiko Yoshida and Shigeto Oda

    Citation: Renal Replacement Therapy 2018 4:13

    Published on:

  12. Content type: Case Report

    TAFRO (thrombocytopenia, anasarca, fever, reticulin myelofibrosis/renal failure, and organomegaly) syndrome is a systemic inflammatory disorder and unique clinicopathological variant of idiopathic multicentric...

    Authors: Arata Hibi, Ken Mizuguchi, Akiko Yoneyama, Takahisa Kasugai, Keisuke Kamiya, Keisuke Kamiya, Chiharu Ito, Satoru Kominato, Toshiyuki Miura and Katsushi Koyama

    Citation: Renal Replacement Therapy 2018 4:16

    Published on:

  13. Content type: Research

    All forms of shock, particularly septic shock, that involve insufficient blood supply to tissues to meet metabolic demands are main causes of morbidity and mortality worldwide and develop in one third of patie...

    Authors: Alexa Hollinger, Lukas Gantner, Franziska Jockers, Thomas Schweingruber, Katrin Ledergerber, Jonas Dominic Scheuzger, Markus Aschwanden, Michael Dickenmann, Johann Knotzer, Jasper van Bommel and Martin Siegemund

    Citation: Renal Replacement Therapy 2018 4:14

    Published on:

  14. Content type: Position statement

    The annual survey of Japanese Society for Dialysis Therapy Renal Data Registry (JRDR) was conducted for 4380 dialysis facilities at the end of 2015, among which 4321 facilities (98.7%) responded. The response ...

    Authors: Ikuto Masakane, Masatomo Taniguchi, Shigeru Nakai, Kenji Tsuchida, Shunsuke Goto, Atsushi Wada, Satoshi Ogata, Takeshi Hasegawa, Takayuki Hamano, Norio Hanafusa, Junichi Hoshino, Jun Minakuchi and Hidetomo Nakamoto

    Citation: Renal Replacement Therapy 2018 4:19

    Published on:

  15. Content type: Position statement

    The necessity of purification of dialysis fluids has been discussed since the 1980s. The Japanese Society for Dialysis Therapy (JSDT) presented a standard for dialysis fluid purification in 1995 and revised th...

    Authors: Michio Mineshima, Hideki Kawanishi, Tomonobu Ase, Tadayuki Kawasaki, Tadashi Tomo and Hidetomo Nakamoto

    Citation: Renal Replacement Therapy 2018 4:15

    Published on:

  16. Content type: Research

    Chronic kidney disease is a major risk factor for dementia, but the influence of hemodialysis itself on the development of dementia remains unclear. We previously reported that non-diabetic patients on mainten...

    Authors: Shigeru Nakai, Kenji Wakai, Eiichiro Kanda, Kazunori Kawaguchi, Kazuyoshi Sakai and Nobuya Kitaguchi

    Citation: Renal Replacement Therapy 2018 4:12

    Published on:

  17. Content type: Research

    This study aimed to explore the role of patient’s characteristic and haematological factors as predictive on the maturation of arteriovenous fistulae in patients who underwent vascular access surgery at the Ro...

    Authors: Muhammad A. Siddiqui, Suhel Ashraff, Derek Santos, Robert Rush, Thomas E. Carline and Zahid Raza

    Citation: Renal Replacement Therapy 2018 4:11

    Published on:

  18. Content type: Research

    In Japan, the most commonly used hemofilters for patients with acute kidney injury (AKI) treated with continuous renal replacement therapy (CRRT) are made of polysulfone membranes. The aim of this study was to...

    Authors: Hideto Yasuda, Kosuke Sekine, Takayuki Abe, Shinichiro Suzaki, Atsushi Katsumi, Naoshige Harada, Hidenori Higashi, Yuki Kishihara, Hidetaka Suzuki and Toru Takebayashi

    Citation: Renal Replacement Therapy 2018 4:6

    Published on:

  19. Content type: Research

    In the patients with severe atherosclerotic renal artery stenosis (ARAS), the evaluation of long-term clinical outcome after percutaneous transluminal renal angioplasty (PTRA) has yet been insufficient. The ai...

    Authors: Yasuhiro Mochida, Takayasu Ohtake, Yusuke Miyashita, Kunihiro Ishioka, Machiko Oka, Kyoko Maesato, Hidekazu Moriya, Sumi Hidaka, Shigeru Saito and Shuzo Kobayashi

    Citation: Renal Replacement Therapy 2018 4:5

    Published on:

  20. Content type: Research

    To cope with the increasing number of patients on long-term hemodialysis (HD), especially those with diabetic nephropathy, we designed a fully automated HD system to decrease staff workload and hence human err...

    Authors: Takashi Shigematsu, Jun Minakuchi, Satoshi Funakoshi, Junichiro Hashiguchi, Hiroshi Yoshimoto, Kyoko Ito, Takuya Ban and Tetsunosuke Kunitomo

    Citation: Renal Replacement Therapy 2018 4:9

    Published on:

  21. Content type: Research

    Patients undergoing hemodialysis (HD) have difficulty performing activities of daily living (ADL) compared to healthy people. ADL difficulty is an early predictor of loss of independence and mortality in older...

    Authors: Takaaki Watanabe, Toshiki Kutsuna, Kei Yoneki, Manae Harada, Takahiro Shimoda, Yusuke Matsunaga, Norio Murayama, Ryota Matsuzawa, Yasuo Takeuchi, Atsushi Yoshida and Atsuhiko Matsunaga

    Citation: Renal Replacement Therapy 2018 4:8

    Published on:

  22. Content type: Review

    Peritoneal dialysis (PD)-related infection encompasses PD-related peritonitis and catheter-related infections, and the latter is used as the collective term to describe exit site infection (ESI) and tunnel inf...

    Authors: Cheuk Chun Szeto

    Citation: Renal Replacement Therapy 2018 4:7

    Published on:

  23. Content type: Research

    The management of renal anemia in the pre-dialysis period has been remarkably improved by long-acting erythropoiesis-stimulating agents (ESA). However, many incident dialysis patients cannot achieve target hem...

    Authors: Shinya Kawamoto, Yu Kaneko, Hideo Misawa, Katsuhiro Nagahori, Atsushi Kitazawa, Atsunori Yoshino and Tetsuro Takeda

    Citation: Renal Replacement Therapy 2018 4:4

    Published on:

Page 1 of 7

2017 Journal Metrics

  • Speed
    33.6 days from submission to first decision
    20.5 days from acceptance to publication

    Usage 
    99,151 downloads

Advertisement